What is X-trodes?
Based in Tel Aviv, Israel, X-trodes operates at the intersection of advanced materials science and digital health. The company is the developer of the world's first scalable wireless Smart Skin, a wearable platform designed for high-fidelity electrophysiological monitoring. By enabling continuous, non-invasive data collection in a patient's natural environment, X-trodes addresses a critical gap in modern medicine: the need for longitudinal, real-world physiological analytics. Their technology facilitates a seamless transition from episodic clinical assessments to continuous, actionable health insights, positioning the firm as a key player in the burgeoning remote patient monitoring and decentralized clinical trial markets.
How much funding has X-trodes raised?
X-trodes has raised a total of $4.5M across 1 funding round:
Angel/Seed
$4.5M
Angel/Seed (2021): $4.5M with participation from Jeremy Coller, Japan Israel High Tech Ventures, and Welltech
Key Investors in X-trodes
Jeremy Coller
A prominent private investor known for supporting high-growth technology ventures and innovative medical solutions.
Japan Israel High Tech Ventures
A specialized investment firm focused on bridging the technological synergies between the Japanese and Israeli innovation ecosystems.
Welltech
A creative solutions firm that specializes in digital transformation, brand development, and strategic growth for organizations operating in the modern digital landscape.
What's next for X-trodes?
With this latest round of financing, X-trodes is strategically positioned to scale its manufacturing capabilities and expand its footprint in global healthcare markets. The company is expected to prioritize the integration of its Smart Skin platform into broader digital health ecosystems, enhancing its analytics suite to provide deeper clinical utility. As the industry shifts toward proactive, data-driven care models, X-trodes' ability to provide high-resolution electrophysiological data will likely serve as a catalyst for new partnerships with pharmaceutical companies and research institutions. The focus remains on refining the user experience for patients while ensuring that the data generated meets the rigorous standards required for clinical decision-making and regulatory approval.
See full X-trodes company page
